medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2023, Number 02

<< Back Next >>

Ginecol Obstet Mex 2023; 91 (02)

Epilepsy and pregnancy: particularities and treatment

Lozano-Vidal M, Carmona-Domínguez E

Language: Spanish
References: 32
Page: 109-118
PDF size: 212.85 Kb.


ABSTRACT

Background: The prevalence of epilepsy in pregnant women is 0.3 to 0.5%. Although it is a low frequency disease, it is important to know how pregnancy modifies the course of the disease and how the disease modifies the course of pregnancy and what is the safety of treatments during pregnancy and what are the current obstetric consensuses in this regard.
Objective: To update knowledge about how pregnancy modifies the course of the disease, how the disease modifies the course of pregnancy, how safe are the treatments during pregnancy and the current obstetric consensus in this respect.
Methodology: Literature review conducted in two databases (PubMed and Scopus) with the following search criteria (MeSH): "epilepsy'' and "pregnancy'' of articles published between 2015 and May 2022, written in English or Spanish: meta-analyses, systematic reviews, narratives or clinical trials.
Results: 310 records were identified. After elimination for duplication and other causes, 20 articles were selected, plus others used to complement the topic.
Conclusions: Pregnancy in a patient with epilepsy should be considered high risk and therefore follow-up should be appropriate. Pregnancy planning is essential in order to indicate the appropriate antiepileptic treatment and folic acid supplementation, if necessary.


REFERENCES

  1. Fisher RS, Acevedo C, Arzimanoglou A, et al. ILAE OfficialReport: A practical clinical definition of epilepsy. Epilepsia 2014; 55 (4): 475-82. doi:10.1111/EPI.12550

  2. Epilepsia. https://www.who.int/en/news-room/factsheets/detail/epilepsy

  3. Viinikainen K, Heinonen S, Eriksson K, Kälviäinen R.Community-based, prospective, controlled study ofobstetric and neonatal outcome of 179 pregnancies inwomen with epilepsy. Epilepsia 2006; 47 (1): 186-92.doi:10.1111/J.1528-1167.2006.00386.X

  4. Harden CL, Hopp J, Ting TY, et al. Management issues forwomen with epilepsy-Focus on pregnancy (an evidencebasedreview): I. Obstetrical complications and change inseizure frequency: Report of the Quality Standards Subcommitteeand Therapeutics and Technology AssessmentSubcommittee of the American Academy of Neurologyand the American Epilepsy Society. Epilepsia 2009; 50 (5):1229-36. doi:10.1111/J.1528-1167.2009.02128.X

  5. Mauri Llerda JA, Suller Marti A, de la Peña Mayor P, et al.The Spanish Society of Neurology’s official clinical practiceguidelines for epilepsy. Special considerations in epilepsy:Comorbidities, women of childbearing age, and elderlypatients. Neurol 2015; 30 (8): 510-17. doi:10.1016/J.NRLENG.2014.08.002

  6. Hammarberg K, Stocker R, Romero L, Fisher J. Pregnancyplanning health information and service needs of womenwith chronic non-communicable conditions: a systematicreview and narrative synthesis. BMC Pregnancy Childbirth2022; 22 (1). doi:10.1186/S12884-022-04498-1

  7. McGrath A, Sharpe L, Lah S, Parratt K. Evaluation of a DecisionAid for Women with Epilepsy Who Are ConsideringPregnancy: A Randomized Controlled Trial. Med Decis Making2017; 37 (5): 589-99. doi:10.1177/0272989X17697304

  8. Whybrow R, Webster LM, Seed PT, Sandall J, Chappell LC.The effectiveness of decision aids for pregnancy relateddecision-making in women with pre-pregnancy morbidity;systematic review and meta-analysis. BMC PregnancyChildbirth 2022; 22 (1). doi:10.1186/S12884-022-04402-X

  9. Kashif T, Fathima N, Usman N, Qaseem A, Jayaraj JS. Womenwith Epilepsy: Anti-epileptic Drugs and Perinatal Outcomes.Cureus 2019; 11 (9). doi:10.7759/CUREUS.5642

  10. Wilson RD, O’Connor DL. Maternal folic acid and multivitaminsupplementation: International clinical evidencewith considerations for the prevention of folate-sensitivebirth defects. Prev Med Reports 2021; 24: 101617.doi:10.1016/J.PMEDR.2021.101617

  11. Shahla M, Hijran B, Sharif M. The course of epilepsy andseizure control in pregnant women. Acta Neurol Belgica2018; 118(3):459-464. doi:10.1007/S13760-018-0974-0

  12. Viale L, Allotey J, Cheong-See F, et al. Epilepsy in pregnancyand reproductive outcomes: a systematic review and metaanalysis.Lancet 2015; 386 (10006):1845-52. doi:10.1016/S0140-6736(15)00045-8

  13. Chen D, Hou L, Duan X, Peng H, Peng B. Effect of epilepsy inpregnancy on fetal growth restriction: a systematic reviewand meta-analysis. Arch Gynecol Obstet 2017; 296 (3):421-27. doi:10.1007/S00404-017-4404-Y

  14. Allotey J, Aroyo-Manzano D, Lopez P, Viale L, Zamora J,Thangaratinam S. Global variation in pregnancy complicationsin women with epilepsy: A meta-analysis. Eur J ObstetGynecol Reprod Biol 2017; 215: 12-19. doi:10.1016/j.ejogrb.2017.05.016

  15. Lavu A, Vaccaro C, Shouman W, Severini SA, Eltonsy S. Antiepilepticdrug exposure during pregnancy and neonatalbirth weight outcomes: protocol for a systematic reviewand meta-analysis. Syst Rev 2021; 10 (1). doi:10.1186/S13643-021-01711-8

  16. Veroniki AA, Cogo E, Rios P, et al. Comparative safety of antiepilepticdrugs during pregnancy: a systematic review andnetwork meta-analysis of congenital malformations andprenatal outcomes. BMC Med 2017; 15 (1). doi:10.1186/S12916-017-0845-1

  17. Morton A. Pregnancy complicated by neurological andneurosurgical conditions – The evidence regardingmode of delivery: https://doi-org.bvsspa.idm.oclc.org/101177/1753495X211000176. 2021;15(1):11-18.doi:10.1177/1753495X211000176

  18. McElrath TF, Druzin ML, Van Marter LJ, et al. The obstetricalcare and delivery experience of women withepilepsy in the MODEAD Study. Am J Perinatol 2022.doi:10.1055/A-1788-4791

  19. Weston J, Bromley R, Jackson CF, et al. Monotherapytreatment of epilepsy in pregnancy: Congenital malformationoutcomes in the child. Cochrane Database SystRev 2016; 2016 (11). doi:10.1002/14651858.CD010224.PUB2/MEDIA/CDSR/CD010224/IMAGE_N/NCD010224-CMP-019-04.PNG

  20. Knight R, Wittkowski A, Bromley RL. Neurodevelopmentaloutcomes in children exposed to newer antiseizure medications:A systematic review. Epilepsia 2021; 62 (8): 1765-79.doi:10.1111/EPI.16953

  21. Scheuerle AE, Holmes LB, Albano JD, et al. LevetiracetamPregnancy Registry: Final results and a review of the impactof registry methodology and definitions on the prevalenceof major congenital malformations. Birth defects Res 2019;111 (13): 872-87. doi:10.1002/BDR2.1526

  22. Pariente G, Leibson T, Shulman T, Adams-Webber T, BarzilayE, Nulman I. Pregnancy outcomes following in utero exposureto lamotrigine: A systematic review and meta-analysis.CNS Drugs 2017; 31. doi:10.1007/s40263-017-0433-0

  23. Veroniki AA, Rios P, Cogo E, et al. Comparative safetyof antiepileptic drugs for neurological development inchildren exposed during pregnancy and breast feeding: asystematic review and network meta-analysis. BMJ 2017; 7(7): e017248. doi:10.1136/BMJOPEN-2017-017248

  24. Athar F, Ehsan M, Farooq M, et al. Adverse Fetal and NeonatalOutcomes following in-utero exposure to Oxcarbazepine:A Systematic Review and Meta-Analysis. Br J ClinPharmacol 2022. doi:10.1111/BCP.15413

  25. Alsaad AMS, Chaudhry SA, Koren G. First trimester exposureto topiramate and the risk of oral clefts in the offspring:A systematic review and meta-analysis. Reprod Toxicol.2015;53:45-50. doi:10.1016/J.REPROTOX.2015.03.003

  26. Tomson T, Battino D, Perucca E. Teratogenicity of antiepilepticdrugs. Curr Opin Neurol. 2019; 32 (2): 246-52.doi:10.1097/WCO.0000000000000659

  27. Gynaecologists RC of O and. Epilepsy in pregnancy. https://www.rcog.org.uk/media/rzldnacf/gtg68_epile.

  28. Epilepsia y embarazo Guía práctica de asistencia publicadaen 2008. https://sego.es/Buscador

  29. Epilepsies in children, young people and adults NICE guideline.Published online 2022. Accessed June 7, 2022. www.nice.org.uk/guidance/ng217

  30. Mauri Llerda JA, Suller Marti A, de la Peña Mayor P, et al.Guía oficial de la Sociedad Española de Neurología de prácticaclínica en epilepsia. Epilepsia en situaciones especiales:comorbilidades, mujer y anciano. Neurología 2015; 30 (8):510-517. doi:10.1016/J.NRL.2014.08.002

  31. Yadav U, Kumar P, Gupta S, Rai V. Distribution of MTHFRC677T Gene Polymorphism in Healthy North Indian Populationand an Updated Meta-analysis. Indian J Clin Biochem2016; 32 (4): 399-410. doi:10.1007/S12291-016-0619-0

  32. Ferrazzi E, Tiso G, Di Martino D. Folic acid versus 5- methyltetrahydrofolate supplementation in pregnancy. Eur J ObstetGynecol Reprod Biol 2020; 253: 312-319. doi:10.1016/J.EJOGRB.2020.06.012




2020     |     www.medigraphic.com